Stock Taper
SCREENER COMPARE ANY 2 STOCKS
TVGN
TEVOGEN BIO HOLDINGS INC.
NASDAQ
$6.89
▲ UP 2.07% (0.14)

KEY STATISTICS

Market Cap$28.69 M
52w High$49.50
52w Low$3.64
Dividend Yield—
Frequency—
P/E-1.18
Volume2.60K
Shares Out.4.16M

COMPANY

LEADERSHIP

Ryan H. Saadi
CHIEF EXECUTIVE
Ryan H. Saadi

COMPENSATION 2026

Salary$501,000
Stock Awards$9,920,000
Incentive Plan Pay$0
All Other Comp.$0
Total$10,421,000

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 5, 2022
METHOD OF GOING PUBLIC
Reverse Merger
FULL TIME EMPLOYEES
18

UPCOMING EARNINGS

DateNov 13, 2026
DayFriday
Rev. Est.—
NOV
13
FRI

SPLIT RECORD

DATETYPERATIO
2026-03-06Reverse1:50

PRICE

$6.89 ▲ UP 2.07% (+$0.14)
OVERLAYS
$6.60$6.75$6.909:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM6.89

About Tevogen Bio Holdings Inc.

https://tevogen.com ↗

Tevogen Bio Holdings Inc. is a clinical-stage biotech company in Warren, NJ, developing off-the-shelf T cell therapies for virology, oncology, and neurology, with lead product TVGN 489 targeting acute COVID-19 and long COVID patients.

INDUSTRY

Biotechnology

A PRODUCT TEVOGEN BIO HOLDINGS INC. IS KNOWN FOR

TVGN 489
TVGN 489

TVGN 489 is an off-the-shelf T cell therapy targeting SARS-CoV-2, developed to treat acute and Long COVID in high-risk and immunocompromised patients.

COMPETITORS

COMPETITOR
ATRA COMPARE
CRBU COMPARE
FATE COMPARE
TCRX COMPARE
TIL COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
11
LISTED HERE
1
RANKED BY POSITION SIZE
VTS.AX
0.00% · 15.1K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
100.00%
HOLDERS
62
TOP 12 OF 62 · RANKED BY POSITION SIZE
Blackrock, Inc.
1.6M sh · $1.22M
Vanguard Group Inc
1.1M sh · $375.27K
Geode Capital Management, LLC
553.2K sh · $183.17K
Goldman Sachs Group Inc
273.7K sh · $90.62K
Morgan Stanley
250.3K sh · $82.86K
Blackrock Inc.
212.9K sh · $153.95K
Northern Trust Corp
195.2K sh · $64.63K
Deutsche Bank AG\
173.7K sh · $57.33K
State Street Corp
132.8K sh · $43.95K
Fmr LLC
106.0K sh · $83.25K
Nuveen, LLC
90.3K sh · $70.88K
Sei Investments Co
90.3K sh · $29.88K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER
Saadi Ryan H.
Purchase · 1.2M shares
2026-07-10
★
DIRECTOR
Feike Jeffrey L.
Purchase · 40.0K shares
2026-07-10
★
DIRECTOR
Patton Curtis L.
Purchase · 40.0K shares
2026-07-10
★
DIRECTOR
PODLOGAR SUSAN M
Purchase · 40.0K shares
2026-07-10

MOST RECENT ANALYST GRADES

GRADE SUMMARY
HOLD 1
1 GRADES IN THE LAST 12 MONTHS
D. Boral Capital HOLD

SECTORS PEERS

PEERPRICE
WHWK$4.62COMPARE
MGNX$4.13COMPARE
GLSI$15.67COMPARE
SRZN$22.42COMPARE
HURA$2.11COMPARE
CGTX$1.02COMPARE
ONCY$0.86COMPARE
CLNN$4.23COMPARE